Effects of phosphoglycerate kinase 1 and pyruvate kinase M2 on metabolism and physiochemical changes in postmortem muscle

Effects of phosphoglycerate kinase 1 and pyruvate kinase M2 on metabolism and physiochemical changes in postmortem muscle

The objective of this work was to investigate the influence of phosphoglycerate kinase-1 (PGK1) and pyruvate kinase-M2 (PKM2) activity on glycolysis, myofibrillar proteins, calpain system, and apoptosis pathways of postmortem muscle. The activity of PGK1 and PKM2 was regulated by their inhibitors an...

Full description

Bibliographic Details
Main Authors:	Caiyan Huang, Dequan Zhang, Christophe Blecker, Yingxin Zhao, Can Xiang, Zhenyu Wang, Shaobo Li, Li Chen
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Food Chemistry: X
Subjects:	PGK1 PKM2 Inhibitors Activators Postmortem muscle Glycolysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590157524000129

Similar Items

Integrated metabolome, proteome, and transcriptome analysis explored the molecular mechanism of phosphoglycerate kinase 1 and pyruvate kinase M2 characterizing the postmortem meat quality
by: Caiyan Huang, et al.
Published: (2024-07-01)

Regulation of phosphoglycerate kinase 1 and its critical role in cancer
by: Kexin Zhang, et al.
Published: (2023-09-01)

Phosphoglycerate Kinase 1: An Effective Therapeutic Target in Cancer
by: Ailin Qiu, et al.
Published: (2024-03-01)

20-Hydroxyecdysone counteracts insulin to promote programmed cell death by modifying phosphoglycerate kinase 1
by: Xin-Le Kang, et al.
Published: (2023-05-01)

The role of NAD-dependent deacetylase sirtuin-2 in liver metabolic stress through regulating pyruvate kinase M2 ubiquitination
by: Jingru Guo, et al.
Published: (2024-07-01)

Pyruvate kinase M2: a potential target for regulating inflammation
by: Jose Carlos eAlves-Filho, et al.
Published: (2016-04-01)

Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
by: Jianshuang Guo, et al.
Published: (2019-10-01)

Sulforaphane diminishes moonlighting of pyruvate kinase M2 and interleukin 1β expression in M1 (LPS) macrophages
by: Sheyda Bahiraii, et al.
Published: (2022-08-01)

Corrigendum: Sulforaphane diminishes moonlighting of pyruvate kinase M2 and interleukin 1β expression in M1 (LPS) macrophages
by: Sheyda Bahiraii, et al.
Published: (2024-04-01)

Podocyte SIRPα reduction in diabetic nephropathy aggravates podocyte injury by promoting pyruvate kinase M2 nuclear translocation
by: Yang Chen, et al.
Published: (2024-12-01)

Targeting phosphoglycerate kinases by tatridin A, a natural sesquiterpenoid endowed with anti-cancer activity, using a proteomic platform
by: Giusy Ferraro, et al.
Published: (2023-09-01)

The Complex of p-Tyr42 RhoA and p-p65/RelA in Response to LPS Regulates the Expression of Phosphoglycerate Kinase 1
by: Oyungerel Dogsom, et al.
Published: (2023-12-01)

Estimation of Pork Quality Traits Using Exsanguination Blood and Postmortem Muscle Metabolites
by: J. H. Choe, et al.
Published: (2015-06-01)

Effect of Calcium Chloride on Energy Level and Quality of Tan Sheep Meat during Postmortem Aging
by: CHEN Xueyan, LUO Ruiming, ZHANG Qian, WANG Jinxia, LI Rong, HU Lijun
Published: (2023-12-01)

BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway
by: Xiuli Liu, et al.
Published: (2022-09-01)

The Regulatory Network of hnRNPs Underlying Regulating <i>PKM</i> Alternative Splicing in Tumor Progression
by: Yuchao Li, et al.
Published: (2024-05-01)

The antiarthritic effect of CBR‐470‐1 in hypoxic environment is to increase the level of NOD‐like receptor family pyrin domain containing 3 ubiquitination by decreasing phosphoglycerate kinase 1 activity
by: Ao Duan, et al.
Published: (2025-01-01)

Protein S-nitrosylation regulates the energy metabolism of early postmortem pork using the in vitro model
by: Wenwei Lu, et al.
Published: (2022-01-01)

Pyruvate Kinase, Inflammation and Periodontal Disease
by: Melissa M. Grant
Published: (2021-06-01)

Icariin inhibits apoptosis in OGD-induced neurons by regulating M2 pyruvate kinase
by: Shan Chen, et al.
Published: (2024-06-01)

Revisiting glucose metabolism in cancer: lessons from a PKM knock-in model
by: Taku Sato, et al.
Published: (2018-07-01)

Myeloid-Specific Pyruvate-Kinase-Type-M2-Deficient Mice Are Resistant to Acute Lung Injury
by: Xinlei Sun, et al.
Published: (2022-05-01)

Design, Synthesis and Biological Evaluation of Quinoline-8-Sulfonamides as Inhibitors of the Tumor Cell-Specific M2 Isoform of Pyruvate Kinase: Preliminary Study
by: Krzysztof Marciniec, et al.
Published: (2023-03-01)

Changes of Serum Pyruvate Kinase M2 Level in Patients with Sepsis and Its Clinical Value
by: Wang L, et al.
Published: (2023-09-01)

Research Progress on the Effect of Post-translational Modification of Pyruvate Kinase on Meat Quality
by: HUANG Xiaolan, CHEN Li, REN Chi, BAI Yuqiang, HOU Chengli, LI Xin, LUO Ruiming, ZHANG Dequan
Published: (2024-08-01)

Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2)
by: Chien-Yi Chan, et al.
Published: (2023-01-01)

Pyruvate Dehydrogenase A1 Phosphorylated by Insulin Associates with Pyruvate Kinase M2 and Induces LINC00273 through Histone Acetylation
by: Abu Jubayer Hossain, et al.
Published: (2022-05-01)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
by: Guiping Wang, et al.
Published: (2020-02-01)

Targeting PGK1: A New Frontier in Breast Cancer Therapy Under Hypoxic Conditions
by: Jiayong Cui, et al.
Published: (2024-10-01)

De Novo Class of Momordicoside with Potent and Selective Tumor Cell Growth Inhibitory Activity as Pyruvate Kinase Muscle Isozyme 2 and Anti-apoptotic Myeloid Leukemia 1 Inhibitors
by: Tope Abraham Ibisanmi, et al.
Published: (2022-12-01)

Long non-coding RNA SRA1 suppresses radiotherapy resistance in esophageal squamous cell carcinoma by modulating glycolytic reprogramming
by: Chen Yurao, et al.
Published: (2024-04-01)

Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC
by: Kaixuan Wang, et al.
Published: (2023-05-01)

Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy
by: Hao L, et al.
Published: (2024-11-01)

Circular RNA circHMCU promotes breast tumorigenesis through miR-4458/PGK1 regulatory cascade
by: Shubian Qiu, et al.
Published: (2023-03-01)

Long non‐coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer
by: Ting Dai, et al.
Published: (2022-10-01)

SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of Oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase
by: Xiaobin Wang, et al.
Published: (2025-01-01)

Research Progress on the Regulatory Mechanism of Very Fast Chilling on the Tenderness of Postmortem Muscle
by: XIAO Zhiyuan, ZHANG Dequan, YAN Tongjing, XU Yuqian, LI Xin, LIU Shanshan, YANG Qingfeng, HOU Chengli
Published: (2024-08-01)

Postmortem liver hypostases in newborns: radiation and pathological characteristics
by: Oksana V. Savva, et al.
Published: (2024-07-01)

The PKM2/HIF-1α Axis is Involved in the Pathogenesis of Endometriosis via TGF-β1 under Endometrial Polyps
by: Jianjuan Li, et al.
Published: (2024-12-01)

Identification of bioactive compounds of Zanthoxylum armatum as potential inhibitor of pyruvate kinase M2 (PKM2): Computational and virtual screening approaches
by: Mohd Afzal, et al.
Published: (2024-03-01)